Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6772774 | 0.92 | HTR6 (0.42) | HTR6PLA2G2A | |
| SCHEMBL6774224 | 0.79 | PLA2G2A (0.39) | PLA2G2A | |
| SCHEMBL8576600 | 0.78 | MEN1 (0.38) | HTR6 | |
| SCHEMBL8576607 | 0.78 | MEN1 (0.38) | — | |
| SCHEMBL6699386 | 0.77 | HTR6 (0.67) | HTR6PLA2G2A | |
| SCHEMBL6774375 | 0.75 | HTR6 (0.48) | HTR6PLA2G2A | |
| SCHEMBL11824216 | 0.70 | HTR6 (0.61) | HTR6PLA2G2A | |
| SCHEMBL11826210 | 0.69 | HTR6 (0.64) | HTR6PLA2G2A | |
| SCHEMBL11826084 | 0.69 | HTR6 (0.66) | HTR6PLA2G2A | |
| SCHEMBL6771051 | 0.68 | PLA2G2A (0.44) | HTR6PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713645-B1 | INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK | ELI LILLY AND COMPANY | 2004-03-30 | — | — | US | disclosed |
| EP-0839806-B1 | Substituted tricyclics | LILLY CO ELI (US) | 2003-07-09 | — | — | EP | disclosed |
| US-6177440-B1 | THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR | ELI LILLY AND COMPANY | 2001-01-23 | — | — | US | disclosed |
| EP-0952149-A2 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors | ELI LILLY AND COMPANY (US) | 1999-10-27 | — | — | EP | disclosed |
| WO-1998018464-A1 | SUBSTITUTED TRICYCLICS | ELI LILLY AND COMPANY (US) | 1998-05-07 | — | — | WO | disclosed |
| EP-0839806-A1 | Substituted tricyclics | ELI LILLY AND COMPANY (US) | 1998-05-06 | — | — | EP | disclosed |